Centre Tightens Surveillance on GLP-1 Weight-Loss Drugs, Bans Surrogate Promotion

The Centre has directed States and UTs to tighten surveillance on GLP-1 weight-loss drugs, banning surrogate advertising and misleading awareness campaigns while strengthening monitoring of their supply chain and promotion.